The insulin-like growth factor (IGF) and sex hormone axes play important roles in endometrial physiology [12, 13], and studies mainly focusing on circulating insulin/IGF and sex hormone axes suggest that these pathways are considerably dysregulated in obesity and diabetes as well as in endometrial cancer development [14]. This evidence concerns the gene INS and obesity disorder.